| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | GABRB1 CACNG3 CACNG2 GABRB3 SLC25A32 CLCN1 SLC16A1 ANO6 SLC6A17 AZGP1 SLC16A14 SCN2A SCN3A CNGB3 SCN7A LRP2 KCNK5 SLC17A7 SLC17A8 SV2C SLC7A5 KCNK13 CACNG5 CACNG4 SLC7A7 SLC44A4 PKDREJ TMC3 LMBRD1 ABCA9 SLC38A6 PLTP RYR1 RYR2 RYR3 SLC17A6 | 1.90e-19 | 1289 | 93 | 36 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 CACNG3 CACNG2 GABRB3 SLC25A32 CLCN1 SLC16A1 ANO6 SLC6A17 AZGP1 SLC16A14 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 SV2C SLC7A5 KCNK13 CACNG5 CACNG4 SLC7A7 SLC44A4 PKDREJ TMC3 ABCA9 SLC38A6 RYR1 RYR2 RYR3 SLC17A6 | 9.63e-18 | 1180 | 93 | 33 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ TMC3 RYR1 RYR2 RYR3 SLC17A6 | 1.46e-16 | 459 | 93 | 22 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ TMC3 RYR1 RYR2 RYR3 SLC17A6 | 2.38e-15 | 525 | 93 | 22 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ TMC3 RYR1 RYR2 RYR3 SLC17A6 | 2.48e-15 | 526 | 93 | 22 | GO:0022803 |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 ANO6 SCN2A CNGB3 SCN7A KCNK5 SLC17A7 KCNK13 CACNG5 CACNG4 TMC3 RYR1 RYR2 RYR3 | 1.56e-14 | 334 | 93 | 18 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 SLC16A1 ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ TMC3 RYR1 RYR2 RYR3 SLC17A6 | 1.17e-12 | 793 | 93 | 23 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 SLC16A1 ANO6 SCN2A SCN3A SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 SLC17A6 | 3.13e-11 | 758 | 93 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNG3 CACNG2 ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 | 5.74e-11 | 343 | 93 | 15 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNG3 CACNG2 SLC16A1 ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 SLC17A6 | 1.83e-10 | 664 | 93 | 19 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNG3 CACNG2 SCN2A SCN3A SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 SLC17A6 | 4.25e-10 | 465 | 93 | 16 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNG3 CACNG2 SLC16A1 SCN2A SCN3A SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 SLC17A6 | 4.24e-09 | 627 | 93 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNG3 CACNG2 CLCN1 ANO6 SCN2A KCNK5 KCNK13 CACNG5 CACNG4 RYR1 | 1.30e-08 | 182 | 93 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNG3 CACNG2 CLCN1 ANO6 SCN2A KCNK5 KCNK13 CACNG5 CACNG4 RYR1 | 1.44e-08 | 184 | 93 | 10 | GO:0022832 |
| GeneOntologyMolecularFunction | L-glutamate uniporter activity | 9.78e-08 | 3 | 93 | 3 | GO:0140788 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.51e-07 | 86 | 93 | 7 | GO:0005254 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.57e-07 | 129 | 93 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.90e-07 | 4 | 93 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 5.21e-07 | 103 | 93 | 7 | GO:0005253 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.25e-07 | 151 | 93 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC25A32 SLC16A1 SLC16A14 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC38A6 SLC17A6 | 5.27e-07 | 207 | 93 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC25A32 SLC16A1 SLC16A14 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC38A6 SLC17A6 | 5.48e-07 | 208 | 93 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 5.79e-07 | 15 | 93 | 4 | GO:0005313 | |
| GeneOntologyMolecularFunction | membrane potential driven uniporter activity | 9.71e-07 | 5 | 93 | 3 | GO:0022810 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 9.73e-07 | 71 | 93 | 6 | GO:0015179 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A32 SLC16A1 SLC16A14 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC44A4 SLC38A6 SLC17A6 | 1.10e-06 | 293 | 93 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.93e-06 | 125 | 93 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.94e-06 | 6 | 93 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 2.02e-06 | 20 | 93 | 4 | GO:0015172 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.32e-06 | 46 | 93 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.33e-06 | 193 | 93 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.87e-06 | 197 | 93 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 6.77e-06 | 151 | 93 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 7.07e-06 | 152 | 93 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 9.63e-06 | 105 | 93 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | uniporter activity | 1.15e-05 | 10 | 93 | 3 | GO:0015292 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.52e-05 | 171 | 93 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.63e-05 | 33 | 93 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 2.09e-05 | 12 | 93 | 3 | GO:0005436 | |
| GeneOntologyMolecularFunction | symporter activity | 7.24e-05 | 150 | 93 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC16A1 SLC6A17 SLC16A14 SLC17A7 SLC17A8 SLC7A5 SLC44A4 SLC17A6 | 7.26e-05 | 296 | 93 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.59e-05 | 18 | 93 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 8.62e-05 | 50 | 93 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 1.22e-04 | 21 | 93 | 3 | GO:0005326 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.49e-04 | 171 | 93 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 1.84e-04 | 24 | 93 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.35e-04 | 26 | 93 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC16A1 SLC6A17 SLC16A14 SLC17A7 SLC17A8 SLC7A5 SLC44A4 ABCA9 SLC17A6 | 3.83e-04 | 477 | 93 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.00e-04 | 31 | 93 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 5.00e-04 | 140 | 93 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 6.12e-04 | 83 | 93 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | protein transporter activity | 9.84e-04 | 42 | 93 | 3 | GO:0140318 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.15e-03 | 11 | 93 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 1.83e-03 | 52 | 93 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.83e-03 | 52 | 93 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 1.88e-03 | 14 | 93 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.88e-03 | 14 | 93 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 1.88e-03 | 14 | 93 | 2 | GO:0035612 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.33e-03 | 119 | 93 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 2.47e-03 | 16 | 93 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 2.79e-03 | 17 | 93 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 3.13e-03 | 18 | 93 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 3.49e-03 | 19 | 93 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 3.49e-03 | 19 | 93 | 2 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 3.49e-03 | 19 | 93 | 2 | GO:0022840 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 3.49e-03 | 19 | 93 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | antiporter activity | 3.97e-03 | 138 | 93 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.44e-03 | 230 | 93 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 4.67e-03 | 22 | 93 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 5.58e-03 | 77 | 93 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | WW domain binding | 6.00e-03 | 25 | 93 | 2 | GO:0050699 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 6.42e-03 | 81 | 93 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.42e-03 | 81 | 93 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.49e-03 | 26 | 93 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 6.98e-03 | 27 | 93 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 6.98e-03 | 27 | 93 | 2 | GO:0015271 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 7.50e-03 | 28 | 93 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 7.74e-03 | 167 | 93 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | channel regulator activity | 8.91e-03 | 174 | 93 | 4 | GO:0016247 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 SLC16A1 ANO6 SLC6A17 SCN2A SCN3A CNGB3 APLNR SCN7A LRP2 KCNK5 SLC17A7 SLC17A8 NDFIP2 KCNK13 CACNG5 CACNG4 PKDREJ TMC3 RYR1 RYR2 RYR3 NDFIP1 SLC17A6 | 5.93e-12 | 1374 | 93 | 28 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 SLC16A1 ANO6 SLC6A17 SCN2A SCN3A CNGB3 APLNR SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ TMC3 RYR1 RYR2 RYR3 SLC17A6 | 1.41e-11 | 1115 | 93 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 SLC16A1 ANO6 SLC6A17 SCN2A SCN3A APLNR SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 SLC17A6 | 9.31e-11 | 1017 | 93 | 23 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNG3 CACNG2 SLC16A1 ANO6 SLC6A17 SCN2A SCN3A CNGB3 APLNR SCN7A LRP2 KCNK5 SLC17A7 SLC17A8 NDFIP2 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 NDFIP1 SLC17A6 | 1.95e-10 | 1157 | 93 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNG3 CACNG2 ANO6 SLC6A17 SCN2A SCN3A APLNR SCN7A LRP2 KCNK5 SLC17A7 SLC17A8 NDFIP2 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 NDFIP1 SLC17A6 | 4.36e-10 | 1000 | 93 | 22 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNG3 CACNG2 SLC16A1 ANO6 SLC6A17 SCN2A SCN3A CNGB3 APLNR SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 SLC17A6 | 9.26e-10 | 942 | 93 | 21 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNG3 CACNG2 SLC16A1 ANO6 SLC6A17 SCN2A SCN3A APLNR SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 SLC17A6 | 3.98e-09 | 922 | 93 | 20 | GO:0098662 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 2.67e-08 | 8 | 93 | 4 | GO:0098943 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.07e-08 | 112 | 93 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | SLC25A32 SLC16A1 LRP2 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC38A6 SLC17A6 | 5.25e-08 | 163 | 93 | 9 | GO:1905039 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC25A32 SLC16A1 LRP2 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC38A6 SLC17A6 | 6.47e-08 | 167 | 93 | 9 | GO:1903825 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 2.68e-07 | 13 | 93 | 4 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 2.68e-07 | 13 | 93 | 4 | GO:0098970 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC25A32 SLC16A1 SLC6A17 SLC16A14 AGTR2 LRP2 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC38A6 SLC17A6 | 3.16e-07 | 410 | 93 | 12 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC25A32 SLC16A1 SLC6A17 SLC16A14 AGTR2 LRP2 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC38A6 SLC17A6 | 3.33e-07 | 412 | 93 | 12 | GO:0015849 |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 3.74e-07 | 14 | 93 | 4 | GO:0098953 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A32 SLC16A1 SLC6A17 SLC16A14 AGTR2 LRP2 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC44A4 SLC38A6 SLC17A6 | 5.29e-07 | 515 | 93 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 5.80e-07 | 108 | 93 | 7 | GO:0015807 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 7.43e-07 | 112 | 93 | 7 | GO:1902476 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 1.18e-06 | 120 | 93 | 7 | GO:0006835 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRB1 PMP22 CACNG2 GABRB3 CLCN1 ANO6 SCN2A SCN3A SCN7A KCNK5 SLC17A7 KCNK13 RYR2 | 1.32e-06 | 559 | 93 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | chloride transport | 1.83e-06 | 128 | 93 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 2.25e-06 | 132 | 93 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.48e-06 | 134 | 93 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 2.69e-06 | 87 | 93 | 6 | GO:1902475 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 4.56e-06 | 25 | 93 | 4 | GO:2000311 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.57e-06 | 208 | 93 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 5.98e-06 | 153 | 93 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | protein localization to lysosome | 7.51e-06 | 60 | 93 | 5 | GO:0061462 | |
| GeneOntologyBiologicalProcess | L-leucine transport | 1.04e-05 | 10 | 93 | 3 | GO:0015820 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNG3 CACNG2 ANO6 APLNR CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 | 1.09e-05 | 392 | 93 | 10 | GO:0070588 |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | CACNG3 CACNG2 ANO6 APLNR AOC3 SLC17A8 SLC7A5 C1QTNF2 CACNG5 CACNG4 CERS1 RYR2 | 1.33e-05 | 589 | 93 | 12 | GO:0034762 |
| GeneOntologyBiologicalProcess | neurotransmitter loading into synaptic vesicle | 1.43e-05 | 11 | 93 | 3 | GO:0098700 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.43e-05 | 11 | 93 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.73e-05 | 120 | 93 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.73e-05 | 180 | 93 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 1.82e-05 | 35 | 93 | 4 | GO:0015813 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.92e-05 | 183 | 93 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | response to dithiothreitol | 2.01e-05 | 2 | 93 | 2 | GO:0072720 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | HPS1 AGTR2 APLNR SCN7A SLC17A7 SLC17A8 GRINA RYR1 RYR2 RYR3 NDFIP1 SLC17A6 | 2.28e-05 | 622 | 93 | 12 | GO:0098771 |
| GeneOntologyBiologicalProcess | bleb assembly | 2.46e-05 | 13 | 93 | 3 | GO:0032060 | |
| GeneOntologyBiologicalProcess | sodium-dependent phosphate transport | 2.46e-05 | 13 | 93 | 3 | GO:0044341 | |
| GeneOntologyBiologicalProcess | amino acid transport | 2.89e-05 | 195 | 93 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 3.12e-05 | 14 | 93 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | branched-chain amino acid transport | 3.12e-05 | 14 | 93 | 3 | GO:0015803 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.45e-05 | 275 | 93 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport | 3.80e-05 | 42 | 93 | 4 | GO:0099637 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 4.18e-05 | 43 | 93 | 4 | GO:0051968 | |
| GeneOntologyBiologicalProcess | organic cation transport | 5.02e-05 | 145 | 93 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | protein localization to vacuole | 5.15e-05 | 89 | 93 | 5 | GO:0072665 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 5.47e-05 | 46 | 93 | 4 | GO:0051938 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNG3 CACNG2 ANO6 APLNR CACNG5 CACNG4 PKDREJ RYR1 RYR2 RYR3 | 9.91e-05 | 509 | 93 | 10 | GO:0006816 |
| GeneOntologyBiologicalProcess | circulatory system process | SLC16A1 PTPRO SLC6A17 SCN2A SCN3A AGTR2 SCN7A AOC3 LRP2 SLC7A5 EMP2 RYR2 | 1.11e-04 | 733 | 93 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | response to caffeine | 1.11e-04 | 21 | 93 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 1.19e-04 | 56 | 93 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 1.36e-04 | 58 | 93 | 4 | GO:0099590 | |
| GeneOntologyBiologicalProcess | phosphate ion homeostasis | 1.47e-04 | 23 | 93 | 3 | GO:0055062 | |
| GeneOntologyBiologicalProcess | vitamin transmembrane transport | 1.47e-04 | 23 | 93 | 3 | GO:0035461 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.56e-04 | 60 | 93 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.77e-04 | 62 | 93 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | folate transmembrane transport | 1.99e-04 | 5 | 93 | 2 | GO:0098838 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 2.03e-04 | 187 | 93 | 6 | GO:0007034 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to vacuole | 2.25e-04 | 66 | 93 | 4 | GO:0072666 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 2.37e-04 | 273 | 93 | 7 | GO:0034764 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.76e-04 | 127 | 93 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | action potential | 3.00e-04 | 201 | 93 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 3.64e-04 | 31 | 93 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of systemic arterial blood pressure | 3.64e-04 | 31 | 93 | 3 | GO:0003071 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 4.10e-04 | 299 | 93 | 7 | GO:0032409 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 4.16e-04 | 7 | 93 | 2 | GO:0071420 | |
| GeneOntologyBiologicalProcess | sensory organ development | GABRB3 LCTL FZD3 CECR2 HPS1 RCN1 SLC17A7 SLC17A8 NOX3 SLC44A4 SLC17A6 | 4.41e-04 | 730 | 93 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 4.51e-04 | 217 | 93 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 5.67e-04 | 84 | 93 | 4 | GO:0008333 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 5.67e-04 | 84 | 93 | 4 | GO:0015800 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 6.17e-04 | 37 | 93 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 6.47e-04 | 153 | 93 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 6.48e-04 | 87 | 93 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 6.48e-04 | 87 | 93 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 6.76e-04 | 88 | 93 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle cell apoptotic process | 7.09e-04 | 9 | 93 | 2 | GO:1905460 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 7.21e-04 | 39 | 93 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 7.77e-04 | 40 | 93 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 7.99e-04 | 92 | 93 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 8.32e-04 | 337 | 93 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 8.32e-04 | 93 | 93 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | inner ear development | 1.00e-03 | 253 | 93 | 6 | GO:0048839 | |
| GeneOntologyBiologicalProcess | response to antibiotic | 1.03e-03 | 44 | 93 | 3 | GO:0046677 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.03e-03 | 44 | 93 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | import into cell | CACNG3 CACNG2 MRC1 ANO6 LRP2 KCNK5 SLC17A7 SLC17A8 SLC7A5 CACNG5 CACNG4 LMBRD1 SLC17A6 | 1.04e-03 | 1074 | 93 | 13 | GO:0098657 |
| GeneOntologyBiologicalProcess | otolith development | 1.08e-03 | 11 | 93 | 2 | GO:0048840 | |
| GeneOntologyBiologicalProcess | folic acid transport | 1.08e-03 | 11 | 93 | 2 | GO:0015884 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 1.13e-03 | 101 | 93 | 4 | GO:0097120 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.13e-03 | 259 | 93 | 6 | GO:0051651 | |
| GeneOntologyBiologicalProcess | action potential propagation | 1.29e-03 | 12 | 93 | 2 | GO:0098870 | |
| GeneOntologyBiologicalProcess | response to histamine | 1.29e-03 | 12 | 93 | 2 | GO:0034776 | |
| GeneOntologyBiologicalProcess | neuronal action potential propagation | 1.29e-03 | 12 | 93 | 2 | GO:0019227 | |
| GeneOntologyBiologicalProcess | acetylcholine transport | 1.29e-03 | 12 | 93 | 2 | GO:0015870 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC16A1 HPS1 AGTR2 APLNR SCN7A SLC17A7 SLC17A8 GRINA CSMD1 RYR1 RYR2 RYR3 NDFIP1 SLC17A6 | 1.38e-03 | 1249 | 93 | 14 | GO:0048878 |
| GeneOntologyBiologicalProcess | receptor internalization | 1.41e-03 | 182 | 93 | 5 | GO:0031623 | |
| GeneOntologyBiologicalProcess | acetate ester transport | 1.52e-03 | 13 | 93 | 2 | GO:1901374 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 CATSPERD ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 RYR1 RYR2 RYR3 SLC17A6 | 1.29e-17 | 378 | 92 | 21 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 CATSPERD ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 RYR1 RYR2 RYR3 SLC17A6 | 8.56e-15 | 523 | 92 | 21 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | GABRB1 CACNG3 CACNG2 GABRB3 CLCN1 CATSPERD ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 KCNK13 CACNG5 CACNG4 RYR1 RYR2 RYR3 SLC17A6 | 2.30e-14 | 550 | 92 | 21 | GO:1990351 |
| GeneOntologyCellularComponent | membrane protein complex | GABRB1 PMP22 CACNG3 TYK2 CACNG2 GABRB3 CLCN1 CATSPERD ANO6 SCN2A SCN3A CNGB3 SCN7A KCNK5 SLC17A7 SLC17A8 NOX3 SLC7A5 OS9 KCNK13 CACNG5 CACNG4 ITGA2B RYR1 RYR2 RYR3 SLC17A6 | 1.43e-10 | 1498 | 92 | 27 | GO:0098796 |
| GeneOntologyCellularComponent | chloride channel complex | 5.61e-09 | 57 | 92 | 7 | GO:0034707 | |
| GeneOntologyCellularComponent | cation channel complex | CACNG3 CACNG2 CATSPERD SCN2A SCN3A CNGB3 SCN7A CACNG4 RYR1 RYR2 RYR3 | 6.93e-09 | 235 | 92 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | calcium channel complex | 3.26e-08 | 73 | 92 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.76e-06 | 46 | 92 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | PMP22 CACNG3 TYK2 CACNG2 CATSPERD SCN2A SCN3A SCN7A NOX3 SLC7A5 CACNG5 CACNG4 ITGA2B RYR1 | 8.23e-06 | 785 | 92 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 8.82e-06 | 30 | 92 | 4 | GO:0032281 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.01e-05 | 201 | 92 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.56e-05 | 45 | 92 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | receptor complex | GABRB1 PMP22 CACNG3 TYK2 CACNG2 GABRB3 IL13RA2 LRP2 CACNG5 CACNG4 ITGA2B | 4.88e-05 | 581 | 92 | 11 | GO:0043235 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.36e-05 | 17 | 92 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | pericellular basket | 5.73e-05 | 3 | 92 | 2 | GO:1990030 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 6.93e-05 | 50 | 92 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CACNG3 CACNG2 GABRB3 MRC1 GPR18 ANO6 SLC6A17 LRP2 SLC17A7 SLC17A8 NDFIP2 SV2C CACNG4 ITGA2B NDFIP1 SLC17A6 | 1.72e-04 | 1307 | 92 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | sarcolemma | 1.94e-04 | 190 | 92 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | vesicle membrane | CACNG3 CACNG2 GABRB3 MRC1 GPR18 ANO6 SLC6A17 LRP2 SLC17A7 SLC17A8 NDFIP2 SV2C CACNG4 ITGA2B NDFIP1 SLC17A6 | 2.01e-04 | 1325 | 92 | 16 | GO:0012506 |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 CACNG3 CACNG2 GABRB3 FZD3 PTPRO ANO6 SCN2A CACNG5 CACNG4 | 2.44e-04 | 583 | 92 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | sodium channel complex | 2.77e-04 | 29 | 92 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | cell surface | PMP22 CACNG2 GABRB3 MRC1 IL13RA2 FZD3 ANO6 AZGP1 AOC3 LRP2 SLC7A5 CACNG4 ITGA2B EMP2 | 3.44e-04 | 1111 | 92 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 6.52e-04 | 157 | 92 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle membrane | 6.76e-04 | 9 | 92 | 2 | GO:0060203 | |
| GeneOntologyCellularComponent | cerebellar mossy fiber | 6.76e-04 | 9 | 92 | 2 | GO:0044300 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle | 6.76e-04 | 9 | 92 | 2 | GO:0060199 | |
| GeneOntologyCellularComponent | junctional membrane complex | 6.76e-04 | 9 | 92 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | laminin complex | 8.43e-04 | 10 | 92 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 8.43e-04 | 10 | 92 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 9.00e-04 | 350 | 92 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.02e-03 | 45 | 92 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.09e-03 | 46 | 92 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 1.17e-03 | 179 | 92 | 5 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 1.17e-03 | 179 | 92 | 5 | GO:0030672 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.28e-03 | 107 | 92 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | side of membrane | TYK2 IL13RA2 TREH AZGP1 ALG9 LRP2 SLC7A5 ITGA2B RYR1 RYR2 RYR3 | 1.58e-03 | 875 | 92 | 11 | GO:0098552 |
| GeneOntologyCellularComponent | sarcoplasm | 1.62e-03 | 114 | 92 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.69e-03 | 503 | 92 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | axon | CACNG2 GABRB3 FZD3 PTPRO AVIL SCN2A SCN3A LRP2 SLC17A7 SLC17A8 SLC17A6 | 1.83e-03 | 891 | 92 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 1.93e-03 | 56 | 92 | 3 | GO:0031234 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.08e-03 | 405 | 92 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | clathrin-sculpted vesicle | 2.21e-03 | 16 | 92 | 2 | GO:0060198 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.24e-03 | 59 | 92 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 3.12e-03 | 19 | 92 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNG3 CACNG2 FZD3 PTPRO SLC6A17 SCN2A SLC17A8 PLEKHA5 CACNG5 CACNG4 | 3.15e-03 | 817 | 92 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | GABA receptor complex | 3.81e-03 | 21 | 92 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CDS1 LCTL SC5D HHAT ALG9 OS9 NCEH1 CERS1 LMBRD1 RYR1 RYR2 RYR3 PIGM | 4.26e-03 | 1293 | 92 | 13 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CDS1 LCTL SC5D HHAT ALG9 OS9 NCEH1 CERS1 LMBRD1 RYR1 RYR2 RYR3 PIGM | 4.43e-03 | 1299 | 92 | 13 | GO:0098827 |
| GeneOntologyCellularComponent | T-tubule | 5.12e-03 | 79 | 92 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CDS1 LCTL SC5D HHAT ALG9 OS9 NCEH1 CERS1 LMBRD1 RYR1 RYR2 RYR3 PIGM | 5.29e-03 | 1327 | 92 | 13 | GO:0042175 |
| GeneOntologyCellularComponent | apical plasma membrane | 5.70e-03 | 487 | 92 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 5.98e-03 | 164 | 92 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 6.91e-03 | 88 | 92 | 3 | GO:0016529 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 7.35e-03 | 90 | 92 | 3 | GO:0016328 | |
| GeneOntologyCellularComponent | integrin complex | 8.72e-03 | 32 | 92 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 9.06e-03 | 185 | 92 | 4 | GO:0009898 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 9.55e-03 | 293 | 92 | 5 | GO:0030658 | |
| GeneOntologyCellularComponent | synaptic vesicle | 1.05e-02 | 300 | 92 | 5 | GO:0008021 | |
| MousePheno | decreased miniature excitatory postsynaptic current amplitude | 6.69e-06 | 7 | 82 | 3 | MP:0014372 | |
| MousePheno | absence of AMPA-mediated synaptic currents | 3.40e-05 | 2 | 82 | 2 | MP:0011001 | |
| MousePheno | abnormal miniature excitatory postsynaptic current amplitude | 8.41e-05 | 15 | 82 | 3 | MP:0014371 | |
| MousePheno | decreased miniature excitatory postsynaptic current frequency | 1.03e-04 | 16 | 82 | 3 | MP:0014376 | |
| MousePheno | impaired swimming | 1.05e-04 | 80 | 82 | 5 | MP:0001522 | |
| MousePheno | abnormal nervous system electrophysiology | 1.29e-04 | 329 | 82 | 9 | MP:0002272 | |
| Domain | VDCC_gsu | 3.97e-08 | 8 | 93 | 4 | IPR008368 | |
| Domain | PMP22_Claudin | 4.34e-08 | 40 | 93 | 6 | PF00822 | |
| Domain | PMP22/EMP/MP20/Claudin | 9.02e-08 | 45 | 93 | 6 | IPR004031 | |
| Domain | Ryanrecept_TM4-6 | 1.20e-07 | 3 | 93 | 3 | IPR009460 | |
| Domain | RyR | 1.20e-07 | 3 | 93 | 3 | PF02026 | |
| Domain | Ryanodine_rcpt | 1.20e-07 | 3 | 93 | 3 | IPR003032 | |
| Domain | RR_TM4-6 | 1.20e-07 | 3 | 93 | 3 | PF06459 | |
| Domain | Ryan_recept | 1.20e-07 | 3 | 93 | 3 | IPR013333 | |
| Domain | Ion_trans_dom | 1.61e-06 | 114 | 93 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.61e-06 | 114 | 93 | 7 | PF00520 | |
| Domain | MFS_1 | 2.31e-06 | 77 | 93 | 6 | PF07690 | |
| Domain | MFS | 2.31e-06 | 77 | 93 | 6 | IPR011701 | |
| Domain | RIH_assoc | 2.36e-06 | 6 | 93 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 2.36e-06 | 6 | 93 | 3 | IPR013662 | |
| Domain | RIH_dom | 2.36e-06 | 6 | 93 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.36e-06 | 6 | 93 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.36e-06 | 6 | 93 | 3 | IPR015925 | |
| Domain | - | 2.36e-06 | 6 | 93 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.36e-06 | 6 | 93 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 2.36e-06 | 6 | 93 | 3 | PF08709 | |
| Domain | Na_channel_asu | 1.40e-05 | 10 | 93 | 3 | IPR001696 | |
| Domain | MIR | 1.40e-05 | 10 | 93 | 3 | PS50919 | |
| Domain | MIR | 1.40e-05 | 10 | 93 | 3 | PF02815 | |
| Domain | MIR | 1.40e-05 | 10 | 93 | 3 | SM00472 | |
| Domain | MIR_motif | 1.40e-05 | 10 | 93 | 3 | IPR016093 | |
| Domain | Na_trans_assoc | 1.40e-05 | 10 | 93 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.40e-05 | 10 | 93 | 3 | PF06512 | |
| Domain | MFS | 1.65e-05 | 108 | 93 | 6 | PS50850 | |
| Domain | NEDD4/Bsd2 | 2.45e-05 | 2 | 93 | 2 | IPR019325 | |
| Domain | DUF2370 | 2.45e-05 | 2 | 93 | 2 | PF10176 | |
| Domain | MFS_dom | 5.57e-05 | 134 | 93 | 6 | IPR020846 | |
| Domain | GABAAb_rcpt | 7.33e-05 | 3 | 93 | 2 | IPR002289 | |
| Domain | Na_trans_cytopl | 3.63e-04 | 6 | 93 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 3.63e-04 | 6 | 93 | 2 | IPR024583 | |
| Domain | PMP22_EMP_MP20 | 8.63e-04 | 9 | 93 | 2 | IPR004032 | |
| Domain | PMP22_2 | 8.63e-04 | 9 | 93 | 2 | PS01222 | |
| Domain | PMP22_1 | 8.63e-04 | 9 | 93 | 2 | PS01221 | |
| Domain | AA_permease_2 | 1.85e-03 | 13 | 93 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 1.85e-03 | 13 | 93 | 2 | IPR002293 | |
| Domain | TIL_dom | 2.15e-03 | 14 | 93 | 2 | IPR002919 | |
| Domain | 2pore_dom_K_chnl | 2.47e-03 | 15 | 93 | 2 | IPR003280 | |
| Domain | Channel_four-helix_dom | 2.88e-03 | 57 | 93 | 3 | IPR027359 | |
| Domain | - | 2.88e-03 | 57 | 93 | 3 | 1.20.120.350 | |
| Domain | EF-hand-dom_pair | 3.12e-03 | 287 | 93 | 6 | IPR011992 | |
| Domain | K_chnl_dom | 4.84e-03 | 21 | 93 | 2 | IPR013099 | |
| Domain | Ion_trans_2 | 4.84e-03 | 21 | 93 | 2 | PF07885 | |
| Domain | AA-permease/SLC12A_dom | 5.31e-03 | 22 | 93 | 2 | IPR004841 | |
| Domain | AA_permease | 5.31e-03 | 22 | 93 | 2 | PF00324 | |
| Domain | GABAA/Glycine_rcpt | 5.80e-03 | 23 | 93 | 2 | IPR006028 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GABRB1 CACNG3 CACNG2 GABRB3 SLC25A32 SCN2A SCN3A SCN7A NOX3 CACNG5 CACNG4 LMBRD1 DNMT1 SLC17A6 | 6.82e-09 | 367 | 75 | 14 | M48346 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.74e-08 | 130 | 75 | 9 | M27454 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 7.09e-08 | 21 | 75 | 5 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 7.09e-08 | 21 | 75 | 5 | M47949 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CLCN1 SLC16A1 ANO6 AZGP1 SLC17A7 SLC17A8 SLC7A5 OS9 NCEH1 SLC7A7 SLC44A4 ABCA9 PLTP RYR1 RYR2 RYR3 SLC17A6 | 7.46e-08 | 681 | 75 | 17 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CLCN1 SLC16A1 ANO6 AZGP1 SLC17A7 SLC17A8 SLC7A5 OS9 NCEH1 SLC7A7 SLC44A4 ABCA9 PLTP RYR1 RYR2 RYR3 SLC17A6 | 2.27e-07 | 736 | 75 | 17 | M27287 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.23e-06 | 203 | 75 | 9 | M5485 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.57e-06 | 74 | 75 | 6 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.57e-06 | 74 | 75 | 6 | M16376 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 5.05e-06 | 83 | 75 | 6 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 8.09e-06 | 90 | 75 | 6 | M835 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 8.59e-06 | 25 | 75 | 4 | M47948 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.76e-05 | 103 | 75 | 6 | MM15196 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.31e-05 | 11 | 75 | 3 | M47958 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.37e-05 | 32 | 75 | 4 | M27455 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 3.07e-05 | 12 | 75 | 3 | M27350 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 3.07e-05 | 12 | 75 | 3 | MM15087 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 3.98e-05 | 13 | 75 | 3 | M39589 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 4.22e-05 | 73 | 75 | 5 | MM16641 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 5.05e-05 | 14 | 75 | 3 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 5.05e-05 | 14 | 75 | 3 | M27564 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 6.18e-05 | 79 | 75 | 5 | M17673 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.32e-04 | 19 | 75 | 3 | M47760 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.81e-04 | 99 | 75 | 5 | MM14910 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.43e-04 | 165 | 75 | 6 | MM15026 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.48e-04 | 106 | 75 | 5 | M27200 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.68e-04 | 238 | 75 | 7 | MM15076 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 2.70e-04 | 24 | 75 | 3 | MM17215 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.71e-04 | 108 | 75 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.83e-04 | 109 | 75 | 5 | MM15074 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 3.06e-04 | 25 | 75 | 3 | M4974 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.52e-04 | 249 | 75 | 7 | M5988 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.58e-04 | 121 | 75 | 5 | M872 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 4.78e-04 | 29 | 75 | 3 | MM15028 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 5.76e-04 | 7 | 75 | 2 | MM15703 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 5.84e-04 | 31 | 75 | 3 | M7223 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.84e-04 | 31 | 75 | 3 | M877 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 7.66e-04 | 8 | 75 | 2 | M45025 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 8.93e-04 | 211 | 75 | 6 | MM14502 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.01e-03 | 144 | 75 | 5 | MM14501 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.49e-03 | 11 | 75 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.49e-03 | 11 | 75 | 2 | M26913 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.00e-03 | 335 | 75 | 7 | MM14503 | |
| Pathway | REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 2.44e-03 | 14 | 75 | 2 | MM15321 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.44e-03 | 176 | 75 | 5 | MM15718 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 2.50e-03 | 177 | 75 | 5 | M27476 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 2.51e-03 | 51 | 75 | 3 | M39457 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 2.80e-03 | 15 | 75 | 2 | MM14762 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.89e-03 | 183 | 75 | 5 | M997 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.95e-03 | 54 | 75 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.95e-03 | 54 | 75 | 3 | MM15202 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.12e-03 | 270 | 75 | 6 | M15514 | |
| Pathway | KEGG_RENIN_ANGIOTENSIN_SYSTEM | 3.61e-03 | 17 | 75 | 2 | M17636 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.45e-10 | 139 | 93 | 9 | 16985003 | |
| Pubmed | Calcium channel gamma subunits: a functionally diverse protein family. | 3.33e-09 | 8 | 93 | 4 | 17652770 | |
| Pubmed | 5.97e-09 | 9 | 93 | 4 | 11170751 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18403125 | ||
| Pubmed | A targeted mutation in Cacng4 exacerbates spike-wave seizures in stargazer (Cacng2) mice. | 1.85e-08 | 3 | 93 | 3 | 15677329 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18434746 | ||
| Pubmed | Lack of evidence for vesicular glutamate transporter expression in mouse astrocytes. | 1.85e-08 | 3 | 93 | 3 | 23467360 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.85e-08 | 3 | 93 | 3 | 9204703 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 14505496 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 7876312 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.85e-08 | 3 | 93 | 3 | 12213830 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 9242641 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.85e-08 | 3 | 93 | 3 | 10788707 | |
| Pubmed | Vesicular Glutamate Transporters (SLCA17 A6, 7, 8) Control Synaptic Phosphate Levels. | 1.85e-08 | 3 | 93 | 3 | 33440152 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.85e-08 | 3 | 93 | 3 | 7621815 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18643873 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 11159936 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.85e-08 | 3 | 93 | 3 | 10473538 | |
| Pubmed | Docking and homology modeling explain inhibition of the human vesicular glutamate transporters. | 1.85e-08 | 3 | 93 | 3 | 17660252 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.85e-08 | 3 | 93 | 3 | 4600883 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 7635066 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 18206662 | ||
| Pubmed | Critical role for TARPs in early development despite broad functional redundancy. | 7.39e-08 | 4 | 93 | 3 | 18634809 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 7.39e-08 | 4 | 93 | 3 | 23413940 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 9384575 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 9607712 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 10613843 | ||
| Pubmed | Functional modulation of AMPA receptors by transmembrane AMPA receptor regulatory proteins. | 7.39e-08 | 4 | 93 | 3 | 18304745 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 23482488 | ||
| Pubmed | A photoswitchable GPCR-based opsin for presynaptic inhibition. | 1.84e-07 | 5 | 93 | 3 | 33979635 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 23918386 | ||
| Pubmed | Protocol to map multi-transmitter neurons in the mouse brain using intersectional strategy. | 1.84e-07 | 5 | 93 | 3 | 36595933 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.84e-07 | 5 | 93 | 3 | 19011160 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.68e-07 | 6 | 93 | 3 | 26025922 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 3.68e-07 | 6 | 93 | 3 | 14592808 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.68e-07 | 6 | 93 | 3 | 25966694 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.68e-07 | 6 | 93 | 3 | 16844763 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 26291162 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 11860456 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 20962236 | ||
| Pubmed | Modulation of tactile feedback for the execution of dexterous movement. | 1.03e-06 | 8 | 93 | 3 | 34648327 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.03e-06 | 8 | 93 | 3 | 19033399 | |
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 11784029 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 31249508 | ||
| Pubmed | Enteroendocrine cell types that drive food reward and aversion. | 1.54e-06 | 9 | 93 | 3 | 35913117 | |
| Pubmed | Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. | 3.01e-06 | 11 | 93 | 3 | 18341993 | |
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 19095005 | ||
| Pubmed | Zinc-α2-glycoprotein as an inhibitor of amine oxidase copper-containing 3. | 7.07e-06 | 2 | 93 | 2 | 32315567 | |
| Pubmed | Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter. | 7.07e-06 | 2 | 93 | 2 | 10820226 | |
| Pubmed | GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies. | 7.07e-06 | 2 | 93 | 2 | 21735059 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 34876472 | ||
| Pubmed | Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle. | 7.07e-06 | 2 | 93 | 2 | 21078869 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 20346423 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21435559 | ||
| Pubmed | Vesicular glutamate transporters VGLUT1 and VGLUT2 in the developing mouse barrel cortex. | 7.07e-06 | 2 | 93 | 2 | 17289331 | |
| Pubmed | Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. | 7.07e-06 | 2 | 93 | 2 | 15118123 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26950270 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18181146 | ||
| Pubmed | Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. | 7.07e-06 | 2 | 93 | 2 | 18650446 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 7.07e-06 | 2 | 93 | 2 | 21531043 | |
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 7.07e-06 | 2 | 93 | 2 | 11245985 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 16678258 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17880893 | ||
| Pubmed | TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating. | 7.07e-06 | 2 | 93 | 2 | 17880894 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 12565913 | ||
| Pubmed | TARP redundancy is critical for maintaining AMPA receptor function. | 7.07e-06 | 2 | 93 | 2 | 18753375 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9489997 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18028110 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17259277 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9192302 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 7.07e-06 | 2 | 93 | 2 | 12640042 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 7.07e-06 | 2 | 93 | 2 | 23016767 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 7.07e-06 | 2 | 93 | 2 | 14722100 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17531353 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27153334 | ||
| Pubmed | Structural and functional interactions within ryanodine receptor. | 7.07e-06 | 2 | 93 | 2 | 26009179 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 7556644 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 32899693 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 14592949 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 8898078 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21800314 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26705736 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 10221464 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 7.07e-06 | 2 | 93 | 2 | 15894801 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30542613 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 37167781 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 14550562 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 7.07e-06 | 2 | 93 | 2 | 11673493 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 11673462 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9799464 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9817784 | ||
| Cytoband | 17q24 | 1.81e-04 | 10 | 93 | 2 | 17q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 1.06e-03 | 98 | 93 | 3 | chr17q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.21e-03 | 797 | 93 | 7 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.24e-03 | 127 | 93 | 3 | chr2q24 | |
| Cytoband | 7q22 | 2.72e-03 | 38 | 93 | 2 | 7q22 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 5.09e-08 | 3 | 68 | 3 | 287 | |
| GeneFamily | Solute carriers | SLC25A32 SLC16A1 SLC6A17 SLC16A14 SLC17A7 SLC17A8 SLC7A5 SLC7A7 SLC44A4 SLC38A6 SLC17A6 | 2.36e-07 | 395 | 68 | 11 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 2.57e-06 | 26 | 68 | 4 | 253 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.93e-04 | 9 | 68 | 2 | 1203 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 4.93e-04 | 9 | 68 | 2 | 430 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 1.42e-03 | 15 | 68 | 2 | 277 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 2.29e-03 | 19 | 68 | 2 | 563 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GABRB1 CACNG2 GABRB3 SLC6A17 SCN2A SCN3A SCN7A SV2C CACNG4 CSMD1 RYR2 SLC17A6 | 7.23e-06 | 703 | 93 | 12 | M39070 |
| Coexpression | GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP | 1.94e-05 | 155 | 93 | 6 | M6860 | |
| CoexpressionAtlas | BM Top 100 - trigeminal ganglia | 7.80e-07 | 75 | 90 | 6 | BM Top 100 - trigeminal ganglia | |
| CoexpressionAtlas | cerebral cortex | GABRB1 CACNG3 CACNG2 GABRB3 CECR2 SLC6A17 SCN2A SCN3A APLNR SLC17A7 SV2C SLC7A5 CACNG5 CACNG4 RXFP1 COLGALT2 CERS1 CSMD1 SLC17A6 | 6.86e-06 | 1428 | 90 | 19 | cerebral cortex |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 1.00e-05 | 116 | 90 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.29e-05 | 455 | 90 | 10 | GSM777055_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.20e-05 | 234 | 90 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200 | 7.54e-05 | 53 | 90 | 4 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k1_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_200 | 8.33e-05 | 169 | 90 | 6 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 9.27e-05 | 21 | 90 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_200 | 1.01e-04 | 175 | 90 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_100 | 1.23e-04 | 60 | 90 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k3 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.60e-04 | 466 | 90 | 9 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#2_top-relative-expression-ranked_200 | 1.78e-04 | 26 | 90 | 3 | gudmap_developingKidney_e13.5_podocyte cells_200_k2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 1.79e-04 | 371 | 90 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 1.92e-04 | 125 | 90 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | BM Top 100 - dorsal root ganglia | 2.36e-04 | 71 | 90 | 4 | BM Top 100 - dorsal root ganglia | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 2.45e-04 | 206 | 90 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | BM Top 100 - amygdala | 2.63e-04 | 73 | 90 | 4 | BM Top 100 - amygdala | |
| CoexpressionAtlas | BM Top 100 - hypothalamus | 2.63e-04 | 73 | 90 | 4 | BM Top 100 - hypothalamus | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.79e-04 | 211 | 90 | 6 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.79e-04 | 211 | 90 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.36e-04 | 141 | 90 | 5 | ratio_SC_vs_MESO_1000_K1 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 3.40e-04 | 408 | 90 | 8 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 3.73e-04 | 80 | 90 | 4 | GSM605856_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 3.91e-04 | 81 | 90 | 4 | GSM605865_100 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_500 | 4.26e-04 | 422 | 90 | 8 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_100 | 5.14e-04 | 87 | 90 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100 | 5.36e-04 | 88 | 90 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.37e-04 | 333 | 90 | 7 | gudmap_kidney_adult_JuxtaGlom_Ren1_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 5.53e-04 | 439 | 90 | 8 | GSM777059_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | GABRB3 CDS1 SLC16A14 SCN2A AOC3 LRP2 NCEH1 GRINA SLC7A7 SLC44A4 PC | 5.55e-04 | 799 | 90 | 11 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_500 | 5.61e-04 | 440 | 90 | 8 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_500 | 6.61e-04 | 93 | 90 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 6.70e-04 | 164 | 90 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | SLC16A1 HHAT SCN2A SCN3A AGTR2 SCN7A AOC3 CPA2 C1QTNF2 SLC7A7 ABCA9 | 6.81e-04 | 819 | 90 | 11 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#2_top-relative-expression-ranked_200 | 6.99e-04 | 41 | 90 | 3 | gudmap_developingKidney_e15.5_Endothelial cells_200_k2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-09 | 167 | 93 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-09 | 195 | 93 | 8 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 93 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 93 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 93 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-07 | 193 | 93 | 7 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-07 | 193 | 93 | 7 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-07 | 195 | 93 | 7 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 196 | 93 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 196 | 93 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-07 | 197 | 93 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-07 | 198 | 93 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.05e-07 | 199 | 93 | 7 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-07 | 200 | 93 | 7 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-07 | 124 | 93 | 6 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.21e-07 | 130 | 93 | 6 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.30e-06 | 165 | 93 | 6 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 169 | 93 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.83e-06 | 175 | 93 | 6 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 179 | 93 | 6 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-06 | 183 | 93 | 6 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.45e-06 | 184 | 93 | 6 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 2.52e-06 | 185 | 93 | 6 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-06 | 186 | 93 | 6 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.77e-06 | 188 | 93 | 6 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-06 | 190 | 93 | 6 | 4cce4ddb79b7751d0103e10f71156977e0c34439 | |
| ToppCell | Severe-Myeloid-Macrophages-FABP4+|Severe / Condition, Lineage, Cell class and cell subclass | 3.13e-06 | 192 | 93 | 6 | 30aad927ad40d8abaf9d0539bf8cb9d88d16f24d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 192 | 93 | 6 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | 343B|World / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-06 | 195 | 93 | 6 | 2290911fde6efacfa38b985a2541322968bee42d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 195 | 93 | 6 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-06 | 195 | 93 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-06 | 195 | 93 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-06 | 196 | 93 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-06 | 196 | 93 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-06 | 196 | 93 | 6 | 48f7516129570981846c667a07abe5a9abe62dcd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-06 | 196 | 93 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-06 | 197 | 93 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 3.63e-06 | 197 | 93 | 6 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-06 | 197 | 93 | 6 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.73e-06 | 198 | 93 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.73e-06 | 198 | 93 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.73e-06 | 198 | 93 | 6 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.73e-06 | 198 | 93 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.73e-06 | 198 | 93 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.73e-06 | 198 | 93 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-06 | 199 | 93 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 199 | 93 | 6 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 199 | 93 | 6 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.96e-06 | 200 | 93 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.96e-06 | 200 | 93 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.96e-06 | 200 | 93 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.96e-06 | 200 | 93 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.96e-06 | 200 | 93 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.96e-06 | 200 | 93 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.96e-06 | 200 | 93 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.96e-06 | 200 | 93 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.96e-06 | 200 | 93 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.96e-06 | 200 | 93 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 200 | 93 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.98e-06 | 113 | 93 | 5 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.98e-06 | 113 | 93 | 5 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.98e-06 | 113 | 93 | 5 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.61e-06 | 129 | 93 | 5 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 146 | 93 | 5 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 147 | 93 | 5 | 2885978bcfc5623967c0c1204dadf5c78c74a082 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 147 | 93 | 5 | 684e2d8d2f0516cf8b0dc53efa7efc3050bbf0d1 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 147 | 93 | 5 | c031fad0a4e192019775809968e46da54a111d27 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-05 | 152 | 93 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-05 | 156 | 93 | 5 | 1a0e081284a99c1b345990775015b8a2fa469496 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 159 | 93 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 160 | 93 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 160 | 93 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 168 | 93 | 5 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-05 | 168 | 93 | 5 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-05 | 168 | 93 | 5 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 3.22e-05 | 174 | 93 | 5 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-05 | 174 | 93 | 5 | 43c0e758fa8683708475aec846929ac70d41d7f5 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.31e-05 | 175 | 93 | 5 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.40e-05 | 176 | 93 | 5 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 177 | 93 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 177 | 93 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 177 | 93 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 177 | 93 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.59e-05 | 178 | 93 | 5 | ccea3c8908d72f5fecd151a133048c8e9758304c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-05 | 180 | 93 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 3.79e-05 | 180 | 93 | 5 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-05 | 180 | 93 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 180 | 93 | 5 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 181 | 93 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 181 | 93 | 5 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 182 | 93 | 5 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 182 | 93 | 5 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 183 | 93 | 5 | 92f54c267135cb5edbcacd26a0f29e62469bb7e5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 183 | 93 | 5 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 183 | 93 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 183 | 93 | 5 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 183 | 93 | 5 | 5c4f7d02ba3a3c4a22ac71302e7c9a47e205eef5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-05 | 184 | 93 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-05 | 184 | 93 | 5 | ce31684772e47a294155f368e50b49753f7c8e87 | |
| Computational | Porins / transporters. | 1.45e-06 | 211 | 57 | 9 | MODULE_63 | |
| Drug | gabapentin | GABRB1 CACNG3 CACNG2 GABRB3 SCN3A SCN7A SLC7A5 CACNG5 CACNG4 GRINA RYR1 RYR2 RYR3 | 2.02e-13 | 169 | 93 | 13 | CID000003446 |
| Drug | riluzole | GABRB1 CACNG2 GABRB3 SCN3A SCN7A KCNK5 SLC17A7 KCNK13 CACNG4 GRINA RYR1 RYR2 RYR3 | 2.94e-13 | 174 | 93 | 13 | CID000005070 |
| Drug | lamotrigine | CACNG3 CACNG2 SCN2A SCN3A SCN7A CACNG5 CACNG4 GRINA RYR1 RYR2 RYR3 | 1.59e-12 | 116 | 93 | 11 | CID000003878 |
| Drug | AC1L2AC7 | 9.87e-12 | 69 | 93 | 9 | CID000068733 | |
| Drug | isradipine | CACNG3 CACNG2 SCN3A SCN7A NCEH1 CACNG5 CACNG4 RYR1 RYR2 RYR3 | 1.01e-11 | 100 | 93 | 10 | CID000003784 |
| Drug | phenytoin | CACNG3 CACNG2 SC5D SCN2A SCN3A SCN7A AOC3 CACNG5 CACNG4 RYR1 RYR2 RYR3 | 9.74e-11 | 219 | 93 | 12 | CID000001775 |
| Drug | potassium | CACNG3 CACNG2 CLCN1 AZGP1 SCN2A SCN3A SCN7A KCNK5 SV2C SLC7A5 OS9 CPA2 KCNK13 CACNG5 CACNG4 GRINA EMP2 SLC7A7 RYR1 RYR2 RYR3 | 5.37e-10 | 1008 | 93 | 21 | CID000000813 |
| Drug | gamma-aminobutyric acid | GABRB1 CACNG2 GABRB3 CLCN1 AOC3 SLC17A7 SLC17A8 CACNG4 GRINA PC RYR1 RYR2 RYR3 DNMT1 SLC17A6 | 8.48e-10 | 474 | 93 | 15 | CID000000119 |
| Drug | sodium | GABRB1 GABRB3 KAT7 SLC16A1 TREH SCN2A SCN3A AGTR2 SCN7A LRP2 KCNK5 SLC17A7 SLC17A8 SLC7A5 SLC7A7 RYR1 RYR2 RYR3 DNMT1 SLC17A6 | 1.11e-09 | 944 | 93 | 20 | CID000000923 |
| Drug | bepridil | 2.37e-09 | 126 | 93 | 9 | CID000002351 | |
| Drug | Cinildipine | 2.97e-09 | 56 | 93 | 7 | CID000002752 | |
| Drug | nilvadipine | 4.88e-09 | 60 | 93 | 7 | CID000004494 | |
| Drug | dihydropyridine | 6.66e-09 | 193 | 93 | 10 | CID000104822 | |
| Drug | lercanidipine | 6.93e-09 | 63 | 93 | 7 | CID000065866 | |
| Drug | mibefradil | 7.75e-09 | 64 | 93 | 7 | CID000060662 | |
| Drug | gallopamil | 1.07e-08 | 67 | 93 | 7 | CID000001234 | |
| Drug | procaine | 1.31e-08 | 153 | 93 | 9 | CID000004914 | |
| Drug | CAS 298-57-7 | 1.97e-08 | 73 | 93 | 7 | CID000002761 | |
| Drug | ethosuximide | 2.17e-08 | 74 | 93 | 7 | CID000003291 | |
| Drug | nisoldipine | 3.15e-08 | 78 | 93 | 7 | CID000004499 | |
| Drug | NSC7524 | 5.90e-08 | 182 | 93 | 9 | CID000005657 | |
| Drug | 2-hydroxycarbazole | 6.60e-08 | 3 | 93 | 3 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 6.60e-08 | 3 | 93 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.60e-08 | 3 | 93 | 3 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.60e-08 | 3 | 93 | 3 | CID005748312 | |
| Drug | 8N3-cADPR | 6.60e-08 | 3 | 93 | 3 | CID000127713 | |
| Drug | aminodantrolene | 6.60e-08 | 3 | 93 | 3 | CID009570289 | |
| Drug | amiloride | CACNG3 CACNG2 SLC17A7 SLC17A8 NDFIP2 CACNG5 CACNG4 PKDREJ RYR1 RYR3 SLC17A6 | 6.64e-08 | 315 | 93 | 11 | CID000016230 |
| Drug | baclofen | 8.93e-08 | 191 | 93 | 9 | CID000002284 | |
| Drug | AC1NUZ8M | 9.96e-08 | 92 | 93 | 7 | CID000073211 | |
| Drug | manidipine | 1.24e-07 | 95 | 93 | 7 | CID000004008 | |
| Drug | Dantrolene-13C3 | 1.44e-07 | 145 | 93 | 8 | CID000002951 | |
| Drug | nimodipine | 1.44e-07 | 145 | 93 | 8 | CID000004497 | |
| Drug | nicardipine | 1.44e-07 | 145 | 93 | 8 | CID000004473 | |
| Drug | nitrendipine | 1.54e-07 | 98 | 93 | 7 | CID000004507 | |
| Drug | Bay K 8644 | 1.87e-07 | 150 | 93 | 8 | CID000002303 | |
| Drug | cyclothiazide | 2.17e-07 | 103 | 93 | 7 | CID000002910 | |
| Drug | CNS 1145 | 2.21e-07 | 33 | 93 | 5 | CID000190902 | |
| Drug | IHC-64 | 2.21e-07 | 33 | 93 | 5 | CID000162753 | |
| Drug | loperamide | 2.48e-07 | 105 | 93 | 7 | CID000003954 | |
| Drug | PCB74 | 2.63e-07 | 4 | 93 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 2.63e-07 | 4 | 93 | 3 | CID006444275 | |
| Drug | SC 38249 | 2.63e-07 | 4 | 93 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 2.63e-07 | 4 | 93 | 3 | CID000035682 | |
| Drug | glutamate | GABRB1 CACNG3 CACNG2 GABRB3 SLC25A32 CLCN1 SLC17A7 SLC17A8 SLC7A5 CPA2 CACNG4 GRINA PC RYR1 RYR2 RYR3 SLC17A6 | 3.17e-07 | 962 | 93 | 17 | CID000000611 |
| Drug | flecainide | 4.56e-07 | 71 | 93 | 6 | CID000003355 | |
| Drug | halothane | GABRB1 CACNG3 CACNG2 GABRB3 KCNK13 CACNG5 CACNG4 RYR1 RYR2 RYR3 | 6.34e-07 | 314 | 93 | 10 | CID000003562 |
| Drug | verapamil | CACNG3 CACNG2 SCN3A SCN7A KCNK5 KCNK13 CACNG5 CACNG4 ABCA9 RYR1 RYR2 RYR3 | 7.41e-07 | 490 | 93 | 12 | CID000002520 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 8.63e-07 | 79 | 93 | 6 | CID005287890 | |
| Drug | pimozide | 9.05e-07 | 127 | 93 | 7 | CID000016362 | |
| Drug | propofol | 1.17e-06 | 191 | 93 | 8 | CID000004943 | |
| Drug | NSC759576 | 1.17e-06 | 191 | 93 | 8 | CID000003075 | |
| Drug | MBED | 1.31e-06 | 6 | 93 | 3 | CID000129958 | |
| Drug | chloro-m-cresol | 1.31e-06 | 6 | 93 | 3 | CID000012008 | |
| Drug | AC1O528X | 1.31e-06 | 6 | 93 | 3 | CID006475857 | |
| Drug | NSC114784 | 1.31e-06 | 6 | 93 | 3 | CID000419425 | |
| Drug | lanthanum | 1.44e-06 | 136 | 93 | 7 | CID000023926 | |
| Drug | isoflurane | 2.14e-06 | 279 | 93 | 9 | CID000003763 | |
| Drug | Azumoleno | 2.28e-06 | 7 | 93 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 2.28e-06 | 7 | 93 | 3 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.28e-06 | 7 | 93 | 3 | CID009547999 | |
| Drug | caffeine | CACNG3 CACNG2 HPS1 AGTR2 CACNG5 CACNG4 GRINA EMP2 SLC38A6 RYR1 RYR2 RYR3 | 3.08e-06 | 562 | 93 | 12 | CID000002519 |
| Drug | T0702 | 3.09e-06 | 25 | 93 | 4 | CID000005908 | |
| Drug | lidocaine | 4.24e-06 | 160 | 93 | 7 | CID000003676 | |
| Drug | taurine | 4.83e-06 | 231 | 93 | 8 | CID000001123 | |
| Drug | IAA-94 | 5.07e-06 | 61 | 93 | 5 | CID000003667 | |
| Drug | phosphine oxide | 5.12e-06 | 107 | 93 | 6 | CID000166931 | |
| Drug | Bicuculline | 5.73e-06 | 29 | 93 | 4 | ctd:D001640 | |
| Drug | felodipine | 6.07e-06 | 169 | 93 | 7 | CID000003333 | |
| Drug | LOPAC | 6.59e-06 | 30 | 93 | 4 | CID000062696 | |
| Drug | PCB 95 | 7.75e-06 | 10 | 93 | 3 | CID000038012 | |
| Drug | AC1NBU2S | 8.57e-06 | 117 | 93 | 6 | CID004473765 | |
| Drug | AC1Q5U59 | 8.68e-06 | 68 | 93 | 5 | CID000005441 | |
| Drug | PCB 66 | 1.06e-05 | 11 | 93 | 3 | CID000036185 | |
| Drug | R 478 | 1.06e-05 | 11 | 93 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.06e-05 | 11 | 93 | 3 | CID003081323 | |
| Drug | rose bengal | 1.39e-05 | 36 | 93 | 4 | CID000025473 | |
| Drug | Ryanodine | 1.41e-05 | 12 | 93 | 3 | ctd:D012433 | |
| Drug | N-methyl-DL-aspartic acid | GABRB1 CACNG3 CACNG2 GABRB3 SLC17A7 CACNG5 CACNG4 GRINA RYR1 RYR2 RYR3 SLC17A6 | 1.44e-05 | 655 | 93 | 12 | CID000004376 |
| Drug | 1,2-dichlorohexafluorocyclobutane | 1.55e-05 | 37 | 93 | 4 | CID000009643 | |
| Drug | sipatrigine | 1.55e-05 | 37 | 93 | 4 | CID000060803 | |
| Drug | 4-chloro-m-cresol | 1.55e-05 | 37 | 93 | 4 | CID000001732 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.65e-05 | 2 | 93 | 2 | ctd:C005147 | |
| Drug | AC1L98DX | 1.73e-05 | 38 | 93 | 4 | CID000439957 | |
| Drug | Cocaine | GABRB1 TYK2 GABRB3 MRC1 THOP1 AZGP1 HPS1 APLNR SLC17A7 SLC17A8 LAMB1 PLEKHA5 GRINA RYR2 RYR3 KIFC1 SLC17A6 | 2.09e-05 | 1314 | 93 | 17 | ctd:D003042 |
| Drug | isovalerate | 2.69e-05 | 143 | 93 | 6 | CID000010430 | |
| Drug | FPL 64176 | 2.90e-05 | 15 | 93 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 2.90e-05 | 15 | 93 | 3 | CID000125015 | |
| Drug | AC1Q5UBL | 3.02e-05 | 146 | 93 | 6 | CID000005466 | |
| Drug | cobalt-60 | 3.13e-05 | 390 | 93 | 9 | CID000061492 | |
| Drug | kazinol B | 4.30e-05 | 17 | 93 | 3 | CID000480869 | |
| Drug | ts M | 4.42e-05 | 48 | 93 | 4 | CID000428025 | |
| Drug | genistein | GABRB1 TYK2 CACNG2 GABRB3 CLCN1 LAMB1 KCNK13 CACNG4 ITGA2B EMP2 PC RYR1 RYR2 RYR3 DNMT1 | 4.48e-05 | 1117 | 93 | 15 | CID005280961 |
| Drug | isotetrandrine | 4.89e-05 | 97 | 93 | 5 | CID000005422 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 4.94e-05 | 3 | 93 | 2 | CID000080262 | |
| Drug | flubendiamide | 4.94e-05 | 3 | 93 | 2 | CID011193251 | |
| Drug | methylcoumarin | 5.15e-05 | 18 | 93 | 3 | CID000007092 | |
| Drug | AC1L380G | 6.10e-05 | 19 | 93 | 3 | CID000084698 | |
| Drug | AC1MW7VF | 6.10e-05 | 19 | 93 | 3 | CID000414699 | |
| Drug | Baclofen | 7.15e-05 | 20 | 93 | 3 | ctd:D001418 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.56e-08 | 3 | 88 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.56e-08 | 3 | 88 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.03e-06 | 10 | 88 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.03e-06 | 10 | 88 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.53e-06 | 12 | 88 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 1.29e-05 | 477 | 88 | 9 | C0005586 | |
| Disease | Schizophrenia | GABRB1 CACNG2 GABRB3 FZD3 HHAT LRP2 SLC17A7 CACNG5 CSMD1 DNMT1 SLC17A6 | 6.35e-05 | 883 | 88 | 11 | C0036341 |
| Disease | heptanoate 7:0 measurement | 8.74e-05 | 5 | 88 | 2 | EFO_0021104 | |
| Disease | eating disorder | 1.19e-04 | 32 | 88 | 3 | EFO_0005203 | |
| Disease | childhood absence epilepsy (is_implicated_in) | 2.43e-04 | 8 | 88 | 2 | DOID:1825 (is_implicated_in) | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 3.55e-04 | 46 | 88 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Diabetic Cardiomyopathies | 4.75e-04 | 11 | 88 | 2 | C0853897 | |
| Disease | serum metabolite measurement | 5.11e-04 | 945 | 88 | 10 | EFO_0005653 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 6.71e-04 | 13 | 88 | 2 | C0751122 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 8.94e-04 | 63 | 88 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | amygdala volume change measurement | 1.03e-03 | 16 | 88 | 2 | EFO_0021490 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 1.45e-03 | 19 | 88 | 2 | EFO_0002609, GO_0031427 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.78e-03 | 80 | 88 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.95e-03 | 22 | 88 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy, remission | 2.14e-03 | 23 | 88 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | arginine measurement | 2.14e-03 | 23 | 88 | 2 | EFO_0020990 | |
| Disease | airway responsiveness measurement | 2.33e-03 | 24 | 88 | 2 | EFO_0006897 | |
| Disease | ICAM-1 measurement | 2.33e-03 | 24 | 88 | 2 | EFO_0004520 | |
| Disease | pallidum volume change measurement, age at assessment | 2.52e-03 | 25 | 88 | 2 | EFO_0008007, EFO_0021494 | |
| Disease | ankylosing spondylitis | 2.58e-03 | 91 | 88 | 3 | EFO_0003898 | |
| Disease | Parkinson disease | 2.77e-03 | 321 | 88 | 5 | MONDO_0005180 | |
| Disease | dihomo-gamma-linolenic acid measurement | 2.94e-03 | 27 | 88 | 2 | EFO_0007763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELVPVEYQWYGFFYG | 406 | O75366 | |
| EYQWYGFFYGGDCYL | 411 | O75366 | |
| SWYFLLCVNYFFYGE | 146 | Q92903 | |
| TYIYYSNTGGFSFWK | 171 | Q86XM0 | |
| VFFVNSLWKGYYEYL | 3351 | Q96PZ7 | |
| EGDDGKTYFYQLWYD | 856 | P26358 | |
| MDYEYGYRSNTFFWI | 1016 | Q8IUA7 | |
| THYLIYGEGFQTWEY | 91 | Q9H6U8 | |
| YYAKDEWPFGEYFCQ | 81 | Q14330 | |
| ATYYSYRYDWLFGPV | 101 | P50052 | |
| KSYSYGWSFYFGAFS | 171 | O60359 | |
| DWSYDYGIKYSFAFE | 366 | P48052 | |
| PLGEDNSGALYWYFY | 146 | Q9BXF3 | |
| WFGLYYNISGAGFFL | 226 | Q16853 | |
| DTNYNLFYWYEGLDH | 166 | Q14627 | |
| SWEEYKQATYGYYLG | 136 | Q15293 | |
| GAGLSWGLYFFFYNA | 91 | Q9H2D1 | |
| ATYTYRDYDWPFGTF | 86 | P35414 | |
| YGEKIGIYFAWLGYY | 291 | Q4KMQ2 | |
| KNSYSYGWSFYFGAL | 171 | Q9Y698 | |
| YGWSFYFGALSFIIA | 176 | Q9Y698 | |
| YGDYKYTYWACGVVL | 416 | P53985 | |
| AFGRYELDTWYHSPY | 341 | O95251 | |
| GFVRENVWTYYVSYA | 191 | Q7Z429 | |
| SAAYYFGNWAFLGVF | 491 | Q9NUN5 | |
| IFYSEQNGLFYDPYW | 251 | Q9BXJ5 | |
| QGWTYSFVASYVEIY | 451 | Q9BW19 | |
| QYYWDVGFYLGAQIL | 436 | O95382 | |
| LYWFFYDGGYINASA | 106 | P55058 | |
| EGWNYIEGLYYSFIT | 186 | O95279 | |
| FEWEKGYSDRYGFYY | 461 | Q6UWM7 | |
| YWVDYFKGNYDFVQA | 251 | Q6PIU2 | |
| ALYSGLFAYGGWNYL | 246 | Q01650 | |
| TAACRFYYFLWGVSY | 101 | Q8TDT2 | |
| FGKTWGVYRYFAYDC | 156 | P07942 | |
| AYFLRGQLYFEEGWY | 61 | Q9P2M1 | |
| SYGYTTDDIEFYWNG | 181 | P18505 | |
| SYGYTTDDIEFYWRG | 181 | P28472 | |
| YTPIEGWSYFDSLYF | 216 | Q9HB14 | |
| FGLTLYGQYIYWTDL | 2596 | P98164 | |
| GIYFYNFGWKDYGVA | 151 | A2A3K4 | |
| EYFNSLLYISWTYGD | 641 | Q16827 | |
| TFAFVSYWHGGYDYL | 371 | Q5VTY9 | |
| FSDYFTGYFNGQYWL | 281 | Q9NV92 | |
| FSTYFPGYFDGQYWL | 166 | Q9BT67 | |
| EGSYGYSYILAWVAF | 136 | P54851 | |
| LYYFWDTDYQEGLRS | 306 | Q8IUX4 | |
| DAETYFNYKYGWSFA | 166 | Q9UF02 | |
| AYLFQTGYGHFSYFW | 466 | Q96PB1 | |
| GLYYGSFLYSETWNI | 101 | P00156 | |
| YGWSFYFGALSFIVA | 181 | Q9UBN1 | |
| WTYEYTDYGGLIFNS | 106 | P00403 | |
| YVFEKYGDNYNWFFL | 126 | P0DN25 | |
| YYFLCYRDTWEDTGQ | 256 | A6NJJ6 | |
| GSWSYSAYLLFGTDY | 111 | P27544 | |
| IGCYFYEQAYRGIWE | 436 | Q9NPG1 | |
| LGVLAYGIYYCWEEY | 266 | Q53GD3 | |
| ANLVEADYSYWTLGY | 486 | Q8IYK4 | |
| LFQEGDFYCSYFLWF | 601 | Q92902 | |
| QESISDFYWYYSGKD | 3926 | P21817 | |
| VQESISDFYWYYSGK | 3881 | Q92736 | |
| EDGWVIYKDYQYYFS | 801 | P22897 | |
| AAWAEYYRQQAAYYG | 676 | Q92945 | |
| VWSLGGYLQYSVLFY | 196 | Q7Z5M5 | |
| DYSAYWIYFVNFLGT | 576 | Q496J9 | |
| FYGELWVCAGLDYDY | 21 | O43897 | |
| GWIYDITQKYDFSFY | 461 | Q7RTX9 | |
| VFYGLTYGYDKSIEW | 1596 | Q9NTG1 | |
| IAEFLTGDYSRYWYL | 151 | Q8IZM9 | |
| YSGWSSVFYVYGSFG | 231 | Q9P2U7 | |
| SVFYVYGSFGIFWYL | 236 | Q9P2U7 | |
| PYYYFQEGWNIFDGI | 816 | Q9NY46 | |
| YFDGYWGYSVAVGEF | 261 | P08514 | |
| GINFYLFIDTFYWYE | 21 | Q9HBY0 | |
| EVLYLGYYQSAFDWD | 141 | Q13438 | |
| VYDGEGNEYLRCYYW | 386 | Q9NQW8 | |
| YFAVRNYWRGFFAAT | 296 | P35523 | |
| LVQYTGWSSVFYVYG | 236 | Q9P2U8 | |
| ISDFYWYYSGKDIID | 3781 | Q15413 | |
| EDIFQLINYYSFSYW | 376 | Q9UM01 | |
| YYYFQEGWNIFDGFI | 816 | Q99250 | |
| RYYYFTIGWNIFDFV | 1586 | Q99250 | |
| GGRFVEFYYWDSYWV | 166 | O43280 | |
| NGWSLQFDKYFASYY | 66 | Q9HBX9 | |
| AWLYQEYNAYLAAGA | 621 | Q92797 | |
| ENNRSSGAFWKYYYD | 126 | P25311 | |
| YYNVIIGWSIFYFFK | 156 | Q9H1V8 | |
| GFKAYFSNGWYRLDF | 991 | Q01118 | |
| GWEEAYTFEGARYYI | 61 | Q9HAU0 | |
| FDYNYGQYFTLWDRI | 236 | O75845 | |
| LAGGYDAQYYGYLWS | 601 | P52888 | |
| LSFGFYYEYGWEFLE | 241 | Q9H3S5 | |
| LNSDYSYGFAYILAW | 126 | Q01453 | |
| VFDYSEYWEGARGLY | 831 | P11498 | |
| LVQYIGWSSVFYIYG | 241 | Q8NDX2 | |
| YYDYEIERFWRGGQY | 371 | Q86VM9 | |
| YAAYIGGYVHYGDWL | 91 | Q96IK0 | |
| YKFYYASDVWSFGVT | 1076 | P29597 | |
| FYNNDYYEPGAEWFS | 1096 | Q9Y493 |